Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
RHHBY ROCHE HOLDING AG
40.750
+0.280+0.69%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(FY)2020/12/31(FY)2019/12/31(FY)2018/12/31
Total revenue
7.68% 62.8B -5.11% 58.32B 8.13% 61.47B 6.65% 56.85B
Operating revenue
7.68% 62.8B -5.11% 58.32B 8.13% 61.47B 6.65% 56.85B
Cost of revenue
21.45% 19.65B -11.85% 16.18B 6.27% 18.35B -5.01% 17.27B
Gross profit
2.39% 43.15B -2.25% 42.15B 8.94% 43.12B 12.69% 39.58B
Operating expense
5.91% 25B -7.68% 23.6B 2.95% 25.57B 12.28% 24.83B
Selling and administrative expenses
5.03% 13.25B -16.34% 12.61B -1.88% 15.08B 15.79% 15.37B
-Selling and marketing expense
3.64% 9.92B -12.66% 9.57B 8.42% 10.96B 2.66% 10.11B
-General and administrative expense
9.43% 3.33B -26.13% 3.04B -21.68% 4.12B 53.52% 5.26B
Research and development costs
13.76% 14.8B 1.84% 13.01B 5.64% 12.77B 7.08% 12.09B
Other operating expenses
-- -- -- -- -- -- -- 26M
Operating profit
-2.09% 18.16B 5.67% 18.54B 19.03% 17.55B 13.38% 14.74B
Net non-operating interest income expense
21.59% -414M 22.92% -528M 9.63% -685M -2.71% -758M
Non-operating interest income
-- -- -83.84% 16M 230.00% 99M 0.00% 30M
Non-operating interest expense
-24.23% 419M -30.09% 553M 6.32% 791M -2.75% 744M
Total other finance cost
44.44% -5M -28.57% -9M -115.91% -7M 1,366.67% 44M
Other net income (expense)
Special income (charges)
-42.86% -20M 93.61% -14M -- -219M -- --
-Less:Other special charges
42.86% 20M -93.61% 14M -- 219M -- --
Income before tax
-3.16% 17.4B 8.13% 17.97B 17.43% 16.61B 15.51% 14.15B
Income tax
-14.98% 2.46B 15.60% 2.9B -23.67% 2.51B -4.09% 3.28B
Net income
-0.88% 14.94B 6.80% 15.07B 29.85% 14.11B 23.12% 10.87B
Net income continuous Operations
-0.88% 14.94B 6.80% 15.07B 29.85% 14.11B 23.12% 10.87B
Minority interest income
30.01% 1.01B 26.51% 773M 67.40% 611M 90.10% 365M
Net income attributable to the parent company
-2.55% 13.93B 5.91% 14.3B 28.54% 13.5B 21.63% 10.5B
Preferred stock dividends
Other preferred stock dividends
0 0 0 0
Net income attributable to common stockholders
-2.55% 13.93B 5.91% 14.3B 28.54% 13.5B 21.63% 10.5B
Basic earnings per share
-2.09% 2.0475 6.09% 2.0913 28.32% 1.9713 21.44% 1.5363
Diluted earnings per share
-1.94% 2.025 5.76% 2.065 27.93% 1.9525 21.61% 1.5263
Dividend per share
5.36% 1.1497 1.48% 1.0912 4.21% 1.0753 0.38% 1.0319
Currency Unit
CHFCHFCHFCHF

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Roche Holding AG operates as a research healthcare company. It operates through the following divisions: Pharmaceuticals and Diagnostics. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
CEO: Dr. Severin Schwan
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist